Membership
Tour
Register
Log in
Medicinal preparations containing organic active ingredients
Follow
Industry
CPC
A61K31/00
This industry / category may be too specific. Please go to a parent level for more data
Parent Industries
A
HUMAN NECESSITIES
A61
Medical science
A61K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Current Industry
A61K31/00
Medicinal preparations containing organic active ingredients
Sub Industries
A61K31/01
Hydrocarbons
A61K31/015
carbocyclic
A61K31/02
Halogenated hydrocarbons
A61K31/025
carbocyclic
A61K31/03
aromatic
A61K31/035
having aliphatic unsaturation
A61K31/04
Nitro compounds
A61K31/045
Hydroxy compounds
A61K31/047
having two or more hydroxy groups
A61K31/05
Phenols
A61K31/055
the aromatic ring being substituted by halogen
A61K31/06
the aromatic ring being substituted by nitro groups
A61K31/065
Diphenyl-substituted acyclic alcohols
A61K31/07
Retinol compounds
A61K31/075
Ethers or acetals
A61K31/08
acyclic
A61K31/085
having an ether linkage to aromatic ring nuclear carbon
A61K31/09
having two or more such linkages
A61K31/095
Sulfur, selenium, or tellurium compounds
A61K31/10
Sulfides Sulfoxides Sulfones
A61K31/105
Persulfides
A61K31/11
Aldehydes
A61K31/115
Formaldehyde
A61K31/12
Ketones
A61K31/121
acyclic
A61K31/122
having the oxygen directly attached to a ring
A61K31/125
Camphor Nuclear substituted derivatives thereof
A61K31/13
Amines
A61K31/131
acylic
A61K31/132
having two or more amino groups
A61K31/133
having hydroxy groups
A61K31/135
having aromatic rings
A61K31/136
having the amino group directly attached to the aromatic ring
A61K31/137
Arylalkylamines
A61K31/138
Aryloxyalkylamines
A61K31/14
Quaternary ammonium compounds
A61K31/145
having sulfur
A61K31/15
Oximes (>C=N-O-) Hydrazines (>N-N<) Hydrazones (>N-N=) Imines (C-N=C)
A61K31/155
Amidines ()
A61K31/16
Amides
A61K31/164
of a carboxlic acid with an aminoalcohol
A61K31/165
having aromatic rings
A61K31/166
having the carbon of a carboxamide group directly attached to the aromatic ring
A61K31/167
having the nitrogen of a carboxamide group directly attached to the aromatic ring
A61K31/17
having the group >N-C(O)-N< or >N-C(S)-N<
A61K31/175
having the group , >N-C(O)-N=N- or
A61K31/18
Sulfonamides
A61K31/185
Acids Anhydrides, halides or salts thereof
A61K31/19
Carboxylic acids
A61K31/191
having two or more hydroxy groups
A61K31/192
having aromatic groups
A61K31/194
having two or more carboxyl groups
A61K31/195
having an amino group
A61K31/196
the amino group being directly attached to a ring
A61K31/197
the amino and the carboxyl group being attached to the same acyclic carbon chain
A61K31/198
Alpha-aminoacids
A61K31/20
having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/201
having one or two double bonds
A61K31/202
having three or more double bonds
A61K31/203
Retinoic acids Salts thereof
A61K31/205
Amine addition salts of organic acids Inner quaternary ammonium salts
A61K31/21
Esters
A61K31/215
of carboxylic acids
A61K31/216
of acids having aromatic rings
A61K31/22
of acyclic acids
A61K31/221
with compounds having an amino group
A61K31/222
with compounds having aromatic groups
A61K31/223
of alpha-aminoacids
A61K31/225
Polycarboxylic acids
A61K31/23
of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/231
having one or two double bonds
A61K31/232
having three or more double bonds
A61K31/235
having an aromatic ring attached to a carboxyl group
A61K31/24
having an amino or nitro group
A61K31/245
Amino benzoic acid types
A61K31/25
with polyoxyalkylated alcohols
A61K31/255
of sulfoxy acids or sulfur analogues thereof
A61K31/26
Cyanate or isoyanate esters Thiocyanate or isothiocyanate esters
A61K31/265
of carbonic, thiocarbonic, or thiocarboxylic acids
A61K31/27
of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
A61K31/275
Nitriles Isonitriles
A61K31/277
having a ring
A61K31/28
Compounds containing heavy metals
A61K31/282
Platinum compounds
A61K31/285
Arsenic compounds
A61K31/29
Antimony or bismuth compounds
A61K31/295
Iron group metal compounds
A61K31/30
Copper compounds
A61K31/305
Mercury compounds
A61K31/31
containing nitrogen
A61K31/315
Zinc compounds
A61K31/32
Tin compounds
A61K31/325
Carbamic acids Thiocarbamic acids Anhydrides or salts thereof
A61K31/327
Peroxy compounds
A61K31/33
Heterocyclic compounds
A61K31/335
having oxygen as the only ring hetero atom
A61K31/336
having three-membered rings
A61K31/337
having four-membered rings
A61K31/34
having five-membered rings with one oxygen as the only ring hetero atom
A61K31/341
not condensed with another ring
A61K31/343
condensed with a carbocyclic ring
A61K31/345
Nitrofurans
A61K31/35
having six-membered rings with one oxygen as the only ring hetero atom
A61K31/351
not condensed with another ring
A61K31/352
condensed with carbocyclic rings
A61K31/353
3,4-Dihydrobenzopyrans
A61K31/355
Tocopherols
A61K31/357
having two or more oxygen atoms in the same ring
A61K31/36
Compounds containing methylenedioxyphenyl groups
A61K31/365
Lactones
A61K31/366
having six-membered rings
A61K31/37
Coumarins
A61K31/375
Ascorbic acid
A61K31/38
having sulfur as a ring hetero atom
A61K31/381
having five-membered rings
A61K31/382
having six-membered rings
A61K31/385
having two or more sulfur atoms in the same ring
A61K31/39
having oxygen in the same ring
A61K31/395
having nitrogen as a ring hetero atom
A61K31/396
having thre-membered rings
A61K31/397
having four-membered rings
A61K31/40
having five-membered rings with one nitrogen as the only ring hetero atom
A61K31/401
Proline Derivatives thereof
A61K31/4015
having oxo groups directly attached to the heterocyclic ring
A61K31/402
1-aryl substituted
A61K31/4025
not condensed and containing further heterocyclic rings
A61K31/403
condensed with carbocyclic rings
A61K31/4035
Isoindoles
A61K31/404
Indoles
A61K31/4045
Indole-alkylamines Amides thereof
A61K31/405
Indole-alkanecarboxylic acids Derivatives thereof
A61K31/407
condensed with other heterocyclic ring systems
A61K31/409
having four such rings
A61K31/41
having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen
A61K31/415
1,2-Diazoles
A61K31/4152
having oxo groups directly attached to the heterocyclic ring
A61K31/4155
non condensed and containing further heterocyclic rings
A61K31/416
condensed with carbocyclic ring systems
A61K31/4162
condensed with heterocyclic ring systems
A61K31/4164
1,3-Diazoles
A61K31/4166
having oxo groups directly attached to the heterocyclic ring
A61K31/4168
having a nitrogen attached in position 2
A61K31/417
Imidazole-alkylamines
A61K31/4172
Imidazole-alkanecarboxylic acids
A61K31/4174
Arylalkylimidazoles
A61K31/4178
not condensed 1,3-diazoles and containing further heterocyclic rings
A61K31/4184
condensed with carbocyclic rings
A61K31/4188
condensed with other heterocyclic ring systems
A61K31/4192
1,2,3-Triazoles
A61K31/4196
1,2,4-Triazoles
A61K31/42
Oxazoles
A61K31/421
1,3-Oxazoles
A61K31/422
not condensed and containing further heterocyclic rings
A61K31/423
condensed with carbocyclic rings
A61K31/424
condensed with heterocyclic ring systems
A61K31/4245
Oxadiazoles
A61K31/425
Thiazoles
A61K31/426
1,3-Thiazoles
A61K31/427
not condensed and containing further heterocyclic rings
A61K31/428
condensed with carbocyclic rings
A61K31/429
condensed with heterocyclic ring systems
A61K31/43
Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula
A61K31/431
containing further heterocyclic rings
A61K31/433
Thidiazoles
A61K31/435
having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/4353
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4355
the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
A61K31/436
the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e..g. rapamycin
A61K31/4365
the heterocyclic ring system having sulfur as a ring hetero atom
A61K31/437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom
A61K31/4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom
A61K31/438
the ring being spiro-condensed with carbocyclic ring systems
A61K31/439
the ring forming part of a bridged ring system
A61K31/44
Non condensed pyridines Hydrogenated derivatives thereof
A61K31/4402
only substituted in position 2
A61K31/4406
only substituted in position 3
A61K31/4409
only substituted in position 4
A61K31/4412
having oxo groups directly attached to the heterocyclic ring
A61K31/4415
Pyridoxine
A61K31/4418
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4422
1,4-Dihydropyridines
A61K31/4425
Pyridinium derivatives
A61K31/4427
containing further heterocyclic ring systems
A61K31/443
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/4433
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4436
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/4439
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/444
containing a six-membered ring with nitrogen as a ring heteroatom
A61K31/445
Non condensed piperidines
A61K31/4453
only substituted in position 1
A61K31/4458
only substituted in position 2
A61K31/4462
only substituted in position 3
A61K31/4465
only substituted in position 4
A61K31/4468
having a nitrogen directly attached in position 4
A61K31/45
having oxo groups directly attached to the heterocyclic ring
A61K31/451
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4515
having a butyrophenone group in position 1
A61K31/452
Piperidinium derivatives
A61K31/4523
containing further heterocyclic ring systems
A61K31/4525
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/453
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4535
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/454
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/4545
containing a six-membered ring with nitrogen as a ring hetero atom
A61K31/455
Nicotinic acids
A61K31/46
8-Azabicyclo [3.2.1] octane Derivatives thereof
A61K31/465
Nicotine Derivatives thereof
A61K31/47
Quinolines Isoquinolines
A61K31/4704
2-Quinolinones
A61K31/4706
4-Aminoquinolines 8-Aminoquinolines
A61K31/4709
Non-condensed quinolines and containing further heterocyclic rings
A61K31/472
Non-condensed isoquinolines
A61K31/4725
containing further heterocyclic rings
A61K31/473
ortho- or peri-condensed with carbocyclic ring systems
A61K31/4738
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4741
condensed with ring systems having oxygen as a ring hetero atom
A61K31/4743
condensed with ring systems having sulfur as a ring hetero atom
A61K31/4745
condensed with ring systems having nitrogen as a ring hetero atom
A61K31/4747
Spiro-condensed
A61K31/4748
forming part of bridged ring systems
A61K31/475
having an indole ring
A61K31/48
Ergoline derivatives
A61K31/485
Morphinan derivatives
A61K31/49
Cinchonan derivatives
A61K31/495
having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms
A61K31/496
Non-condensed piperazines containing further heterocyclic rings
A61K31/4965
Non-condensed pyrazines
A61K31/497
containing further heterocyclic rings
A61K31/498
Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems
A61K31/4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61K31/499
Spiro-condensed pyrazines or piperazines
A61K31/4995
Pyrazines or piperazines forming part of bridged ring systems
A61K31/50
Pyridazines Hydrogenated pyridazines
A61K31/501
not condensed and containing further heterocyclic rings
A61K31/502
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5025
ortho- or peri-condensed with heterocyclic ring systems
A61K31/503
spiro-condensed
A61K31/504
forming part of bridged ring systems
A61K31/505
Pyrimidines Hydrogenated pyrimidines
A61K31/506
not condensed and containing further heterocyclic rings
A61K31/51
Thiamines
A61K31/513
having oxo groups directly attached to the heterocyclic ring
A61K31/515
Barbituric acids Derivatives thereof
A61K31/517
ortho- or peri-condensed with carbocyclic ring systems
A61K31/519
ortho- or peri-condensed with heterocyclic rings
A61K31/52
Purines
A61K31/522
having oxo groups directly attached to the heterocyclic ring
A61K31/525
Isoalloxazines
A61K31/527
spiro-condensed
A61K31/529
forming part of bridged ring systems
A61K31/53
having six-membered rings with three nitrogens as the only ring hetero atoms
A61K31/535
having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms
A61K31/5355
non-condensed oxazines and containing further heterocyclic rings
A61K31/536
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5365
ortho- or peri-condensed with heterocyclic ring systems
A61K31/537
spiro-condensed or forming part of bridged ring systems
A61K31/5375
1,4-Oxazines
A61K31/5377
not condensed and containing further heterocyclic rings
A61K31/538
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5383
ortho- or peri-condensed with heterocyclic ring systems
A61K31/5386
Spiro-condensed or forming part of bridged ring systems
A61K31/539
having two or more oxygen atoms in the same ring
A61K31/5395
having two or more nitrogen atoms in the same ring
A61K31/54
having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms
A61K31/541
non-condensed thiazines containing further heterocyclic rings
A61K31/5415
ortho- or peri-condensed with carbocyclic ring systems
A61K31/542
ortho- or peri-condensed with heterocyclic ring systems
A61K31/545
Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
A61K31/546
containing further heterocyclic rings
A61K31/547
spiro-condensed or forming part of bridged ring systems
A61K31/548
having two or more sulfur atoms in the same ring
A61K31/549
having two or more nitrogen atoms in the same ring
A61K31/55
having seven-membered rings
A61K31/551
having two nitrogen atoms
A61K31/5513
1,4-Benzodiazepines
A61K31/5517
condensed with five-membered rings having nitrogen as a ring hetero atom
A61K31/553
having at least one nitrogen and one oxygen as ring hetero atoms
A61K31/554
having at least one nitrogen and one sulfur as ring hetero atoms
A61K31/555
containing heavy metals
A61K31/557
Eicosanoids
A61K31/5575
having a cyclopentane
A61K31/5578
having a pentalene ring system
A61K31/558
having heterocyclic rings containing oxygen as the only ring hetero atom
A61K31/5585
having five-membered rings containing oxygen as the only ring hetero atom
A61K31/559
having heterocyclic rings containing hetero atoms other than oxygen
A61K31/56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems Derivatives
A61K31/565
not substituted in position 17 beta by a carbon atom
A61K31/566
having an oxo group in position 17
A61K31/567
substituted in position 17 alpha
A61K31/568
substituted in positions 10 and 13 by a chain having at least one carbon atom
A61K31/5685
having an oxo group in position 17
A61K31/569
substituted in position 17 alpha
A61K31/57
substituted in position 17 beta by a chain of two carbon atoms
A61K31/573
substituted in position 21
A61K31/575
substituted in position 17 beta by a chain of three or more carbon atoms
A61K31/58
containing heterocyclic rings
A61K31/585
containing lactone rings
A61K31/59
Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
A61K31/592
9,10-Secoergostane derivatives, e.g. ergocalciferol
A61K31/593
9,10-Secocholestane derivatives, e.g. cholecalciferol
A61K31/60
Salicylic acid Derivatives thereof
A61K31/603
having further aromatic rings
A61K31/606
having amino groups
A61K31/609
Amides
A61K31/612
having the hydroxy group in position 2 esterified
A61K31/616
by carboxylic acids
A61K31/618
having the carboxyl group in position 1 esterified
A61K31/621
having the hydroxy group in position 2 esterified
A61K31/625
having heterocyclic substituents
A61K31/63
Compounds containing para-N-benzenesulfonyl-N-groups
A61K31/635
having a heterocyclic ring
A61K31/64
Sulfonylureas
A61K31/65
Tetracyclines
A61K31/655
Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
A61K31/66
Phosphorus compounds
A61K31/661
Phosphorus acids or esters thereof not having P-C bonds
A61K31/6615
Compounds having two or more esterified phosphorus acid groups
A61K31/662
Phosphorus acids or esters thereof having P-C bonds
A61K31/663
Compounds having two or more phosphorus acid groups or esters thereof
A61K31/664
Amides of phosphorus acids
A61K31/665
having oxygen as a ring hetero atom
A61K31/67
having sulfur as a ring hetero atom
A61K31/675
having nitrogen as a ring hetero atom
A61K31/683
Diesters of a phosphorus acid with two hydroxy compounds
A61K31/685
one of the hydroxy compounds having nitrogen atoms
A61K31/688
both hydroxy compounds having nitrogen atoms
A61K31/69
Boron compounds
A61K31/695
Silicon compounds
A61K31/70
Carbohydrates Sugars Derivatives thereof
A61K31/7004
Monosaccharide having only carbon, hydrogen and oxygen atoms
A61K31/7008
Compounds having an amino group directly attached to a carbon atom of the saccharide radical
A61K31/7012
Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical
A61K31/7016
Disaccharides
A61K31/702
Oligosaccharides
A61K31/7024
Esters of saccharides
A61K31/7028
Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K31/7032
attached to a polyol, i.e. compound having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage
A61K31/7034
attached to a carbocyclic compound
A61K31/7036
having at least one amino group directly attached to the carbocyclic ring
A61K31/704
attached to a condensed carbocyclic ring system
A61K31/7042
Compounds having saccharide radicals and heterocyclic rings
A61K31/7048
having oxygen as a ring hetero atom
A61K31/7052
having nitrogen as a ring hetero atom
A61K31/7056
containing five-membered rings with nitrogen as a ring hetero atom
A61K31/706
containing six-membered rings with nitrogen as a ring hetero atom
A61K31/7064
containing condensed or non-condensed pyrimidines
A61K31/7068
having oxo groups directly attached to the pyrimidine ring
A61K31/7072
having two oxo groups directly attached to the pyrimidine ring
A61K31/7076
containing purines
A61K31/708
having oxo groups directly attached to the purine ring system
A61K31/7084
Compounds having two nucleosides or nucleotides
A61K31/7088
Compounds having three or more nucleosides or nucleotides
A61K31/7105
Natural ribonucleic acids
A61K31/711
Natural deoxyribonucleic acids
A61K31/7115
Nucleic acids or oligonucleotides having modified bases
A61K31/712
Nucleic acids or oligonucleotides having modified sugars
A61K31/7125
Nucleic acids or oligonucleotides having modified internucleoside linkage
A61K31/713
Double-stranded nucleic acids or oligonucleotides
A61K31/7135
Compounds containing heavy metals
A61K31/714
Cobalamins, e.g. cyanocobalamin
A61K31/715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages Derivatives thereof
A61K31/716
Glucans
A61K31/717
Celluloses
A61K31/718
Starch or degraded starch
A61K31/719
Pullulans
A61K31/721
Dextrans
A61K31/722
Chitin, chitosan
A61K31/723
Xanthans
A61K31/724
Cyclodextrins
A61K31/726
Glycosaminoglycans
A61K31/727
Heparin Heparan
A61K31/728
Hyaluronic acid
A61K31/729
Agar Agarose Agaropectin
A61K31/731
Carrageenans
A61K31/732
Pectin
A61K31/733
Fructosans
A61K31/734
Alginic acid
A61K31/736
Glucomannans or galactomannans
A61K31/737
Sulfated polysaccharides
A61K31/738
Cross-linked polysaccharides
A61K31/739
Lipopolysaccharides
A61K31/74
Synthetic polymeric materials
A61K31/745
Polymers of hydrocarbons
A61K31/75
of ethene
A61K31/755
Polymers containing halogen
A61K31/76
of vinyl chloride
A61K31/765
Polymers containing oxygen
A61K31/77
of oxiranes
A61K31/775
Phenolic resins
A61K31/78
of acrylic acid or derivatives thereof
A61K31/785
Polymers containing nitrogen
A61K31/787
containing heterocyclic rings having nitrogen as a ring hetero atom
A61K31/79
Polymers of vinyl pyrrolidone
A61K31/795
Polymers containing sulfur
A61K31/80
Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
Industries
Overview
Organizations
People
Information
Impact
Please log in for detailed analytics
Patents Grants
last 30 patents
Information
Patent Grant
Formulations of terameprocol and temozolomide and their use in stim...
Patent number
12,171,729
Issue date
Dec 24, 2024
The Johns Hopkins University
Ru Chih C. Huang
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compositions and use of N-chlorotaurine for treatment and preventio...
Patent number
12,171,732
Issue date
Dec 24, 2024
Markus Nagl
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Pathogenic bacteria
Patent number
12,171,734
Issue date
Dec 24, 2024
Sporegen Limited
Simon Cutting
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Grant
Compositions and methods for treating allergic inflammatory conditions
Patent number
12,171,740
Issue date
Dec 24, 2024
Children's Hospital Medical Center
Nurit P. Azouz
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Pharmaceutical combinations for the treatment of cancer
Patent number
12,171,744
Issue date
Dec 24, 2024
PreSage Biosciences, Inc.
Richard Klinghoffer
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Isoxazoline parasiticide formulations and methods for treating blep...
Patent number
12,171,750
Issue date
Dec 24, 2024
Tarsus Pharmaceuticals, Inc.
Bobak Robert Azamian
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of treating cancers with CT45 targeted therapies
Patent number
12,173,042
Issue date
Dec 24, 2024
The University of Chicago
Ernst Lengyel
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Application of raman spectroscopy for the manufacture of inhalation...
Patent number
12,174,121
Issue date
Dec 24, 2024
Norton (Waterford) Limited
Hardik Kirtikumar Shah
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Crystalline salt forms of kappa opioid receptor antagonist and prod...
Patent number
12,171,758
Issue date
Dec 24, 2024
NEUMORA THERAPEUTICS, INC.
Brian Van Dyke
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods and uses for treating anhedonia
Patent number
12,171,759
Issue date
Dec 24, 2024
Xenon Pharmaceuticals Inc.
Simon Neil Pimstone
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Bioavailable solid state (17-beta)-hydroxy-4-androsten-3-one esters
Patent number
12,171,770
Issue date
Dec 24, 2024
Mahesh V. Patel
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of treating myelodysplastic syndrome
Patent number
12,171,778
Issue date
Dec 24, 2024
Geron Corporation
Aleksandra Rizo
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Polysilane methacrylic compounds and methods of making them
Patent number
12,171,780
Issue date
Dec 24, 2024
Zetagen Therapeutics, Inc.
Bryan S. Margulies
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method of activating lactic acid bacteria
Patent number
12,171,793
Issue date
Dec 24, 2024
INFANT BACTERIAL THERAPEUTICS AB
Staffan Stromberg
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Methods of and compositions for reducing gene expression and/or act...
Patent number
12,171,813
Issue date
Dec 24, 2024
Christiana Care Gene Editing Institute, Inc.
Eric B. Kmiec
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Topical sanitizing formulations and uses thereof
Patent number
12,171,853
Issue date
Dec 24, 2024
Innovative BioDefense, Inc.
Jesse Cozean
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Biological self-assembled nanocrystal injection having a lymphatic...
Patent number
12,171,864
Issue date
Dec 24, 2024
SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD
Jun Liu
B82 - NANO-TECHNOLOGY
Information
Patent Grant
Contact lens packaging solutions
Patent number
12,171,871
Issue date
Dec 24, 2024
Alcon Inc.
Junhao Ge
A45 - HAND OR TRAVELLING ARTICLES
Information
Patent Grant
Oral compositions and methods of manufacture
Patent number
12,171,872
Issue date
Dec 24, 2024
NICOVENTURES TRADING LIMITED
Darrell Eugene Holton
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Solid forms and methods of preparing the same
Patent number
12,171,881
Issue date
Dec 24, 2024
University of Central Lancashire
Mohamed Albed Alhnan
B29 - WORKING OF PLASTICS WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
Information
Patent Grant
Organic compound salts
Patent number
12,172,960
Issue date
Dec 24, 2024
GH RESEARCH IRELAND LIMITED
Julian Northen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
4-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]butanoic acid...
Patent number
12,172,968
Issue date
Dec 24, 2024
KING FAISAL UNIVERSITY
Hany Mohamed Abd El-Lateef Ahmed
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Prodrugs of riluzole and their method of use
Patent number
12,172,974
Issue date
Dec 24, 2024
Biohaven Pharmaceutical Holding Company Ltd.
Garry Robert Smith
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Pyrido[3,4-e][1,2,4]triazolo[4,3-c]pyrimidines as CK2 inhibitors
Patent number
12,173,001
Issue date
Dec 24, 2024
KING FAISAL UNIVERSITY
Michelyne Haroun
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of making polytetrafluoroethylene/polymer composites and us...
Patent number
12,173,125
Issue date
Dec 24, 2024
Wisconsin Alumni Research Foundation
Lih-Sheng Turng
B29 - WORKING OF PLASTICS WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
Information
Patent Grant
Vilazodone inclusion complexes, compositions and preparation thereof
Patent number
12,171,761
Issue date
Dec 24, 2024
SUNSHINE LAKE PHARMA CO., LTD.
Dailong Fang
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods and compositions comprising a KRASG12C inhibitor and a PD-L...
Patent number
12,171,763
Issue date
Dec 24, 2024
Genentech, Inc.
Marie Evangelista
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of treating patients suffering from brain injury and method...
Patent number
12,171,766
Issue date
Dec 24, 2024
VERINOS OPERATIONS GMBH
John Stover
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Uses of DPP IV inhibitors
Patent number
12,171,767
Issue date
Dec 24, 2024
Boehringer Ingelheim International GmbH
Klaus Dugi
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Tryptamine compositions for enhancing neurite outgrowth
Patent number
12,171,771
Issue date
Dec 24, 2024
TURTLE BEAR HOLDINGS, LLC
Paul Edward Stamets
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
COMPOSITION FOR ALLEVIATING HAIR LOSS AND PROMOTING HAIR GROWTH COM...
Publication number
20240424049
Publication date
Dec 26, 2024
Konkuk University Industrial Cooperation Corp.
Sun Hee DO
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TR...
Publication number
20240424053
Publication date
Dec 26, 2024
TUFTS MEDICAL CENTER, INC.
Athan KULIOPULOS
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
Publication number
20240424105
Publication date
Dec 26, 2024
ARBUTUS BIOPHARMA CORPORATION
Muthiah Manoharan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
AMIDE CONTAINING LIPIDS
Publication number
20240423914
Publication date
Dec 26, 2024
Acuitas Therapeutics, Inc.
Jason Samuel Tan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVE...
Publication number
20240423916
Publication date
Dec 26, 2024
Matinas BioPharma Nanotechnologies, Inc.
Raphael J. MANNINO
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
EFFECT OF GLYCEROL ON BIOFILM FORMING BACTERIA AND FUNGI THAT CHANG...
Publication number
20240423929
Publication date
Dec 26, 2024
Thomas Bryan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
DRUGS FOR TREATING NEURODEVELOPMENTAL DISORDERS
Publication number
20240423933
Publication date
Dec 26, 2024
President and Fellows of Harvard College
Richard Novak
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS IN THE FORM OF A UREA POWDER
Publication number
20240423934
Publication date
Dec 26, 2024
KidneyAide
Barry Gorlitsky
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
FUNCTIONAL GUM COMPRISING AN ALGINATE BLEND
Publication number
20240423938
Publication date
Dec 26, 2024
Reflux Gourmet LLC
Ken Frank
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Application
PHARMACEUTICAL COMPOSITION INCLUDING RETINOIC ACID AND CARBOHYDRATE...
Publication number
20240423942
Publication date
Dec 26, 2024
Mastery Biotech CO., LTD.
Ching-Yu Chen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF LAURYL GALLATE (LG) AS A HEMOSTATIC AGENT
Publication number
20240423944
Publication date
Dec 26, 2024
CENTRE DE BIOTECHNOLOGIE DE SFAX (CBS)
Basma HADJKACEM
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Chlorthalidone Compositions And Methods
Publication number
20240423954
Publication date
Dec 26, 2024
Nivagen Pharmaceuticals, Inc.
Govind R. Jagadale
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
C-7 FUNCTIONALIZED ARTEMISININ DERIVATIVES FOR THE TREATMENT OF MAL...
Publication number
20240423958
Publication date
Dec 26, 2024
University of the Incarnate Word
Paulo Carvalho
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDI...
Publication number
20240423970
Publication date
Dec 26, 2024
Harrow IP, LLC
Dennis E. Saadeh
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
APPLICATION OF RIP2 INHIBITOR COMBINED WITH CHEMOTHERAPY DRUG
Publication number
20240423971
Publication date
Dec 26, 2024
NINGBO COMBIREG PHARMACEUTICAL TECHNOLOGY CO., LTD.
Gang LIU
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CHEMOTHERAPEUTIC BIOADHESIVE PARTICLES WITH IMMUNOSTIMULATORY MOLEC...
Publication number
20240423972
Publication date
Dec 26, 2024
Yale University
Hee-Won Suh
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS
Publication number
20240423986
Publication date
Dec 26, 2024
Sun Pharmaceutical Industries, Inc.
Amanda T. WAGNER
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-M...
Publication number
20240423996
Publication date
Dec 26, 2024
Essentialis, Inc.
Neil M. COWEN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS OF TREATING AGITATION AND OTHER DEMENTIA-ASSOCIATED BEHAVIO...
Publication number
20240423998
Publication date
Dec 26, 2024
Woolsey Pharmaceuticals, Inc.
Thomas MACALLISTER
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
DETOXIFYING AGENT, DETOXIFYING AGENT KIT, AND NOVEL INCLUSION COMPLEX
Publication number
20240423999
Publication date
Dec 26, 2024
The Doshisha
Hiroaki KITAGISHI
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMBINATION OF TLR LIGANDS, COMPOUNDS LABELLING TUMORS FOR IMMUNE A...
Publication number
20240424004
Publication date
Dec 26, 2024
BIOCANIM A.S.
Jan ŽENKA
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SWALLOWABLE DRUG DELIVERY DEVICE AND METHODS OF DRUG DELIVERY
Publication number
20240424268
Publication date
Dec 26, 2024
Rani Therapeutics, LLC
Mir Imran
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS FOR MANUFACTURING SMALL MOLECULE BIOACTIVES
Publication number
20240423255
Publication date
Dec 26, 2024
Brightseed, Inc.
Gul Konuklar
A21 - BAKING EDIBLE DOUGHS
Information
Patent Application
Means and Methods for Chronic Wound Healing
Publication number
20240425857
Publication date
Dec 26, 2024
VIB VZW
Kodimangalam Ravichandran
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PARN AS A BIOMARKER AND THERAPEUTIC TARGET
Publication number
20240425866
Publication date
Dec 26, 2024
The Regents of the University of Colorado, a Body Corporate
Roy R. Parker
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
BORIC ACID DERIVATIVE
Publication number
20240425529
Publication date
Dec 26, 2024
SHOUYAO HOLDINGS (BEIJING) CO., LTD.
Yeliu WANG
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITI...
Publication number
20240425512
Publication date
Dec 26, 2024
280 Bio, Inc
Zusheng XU
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF
Publication number
20240425516
Publication date
Dec 26, 2024
SUMITOMO PHARMA AMERICA, INC.
Andrea BAUER
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
BCL-2 INHIBITORS
Publication number
20240425520
Publication date
Dec 26, 2024
Newave Pharmaceutical Inc.
Yi Chen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Compounds for the Degradation of EGFR Kinase
Publication number
20240425523
Publication date
Dec 26, 2024
BEIGENE SWITZERLAND GMBH
Huaqing Liu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE